FHLC offers broader sector exposure at a 0.08% expense ratio, compared with IBB's concentrated biotech focus at 0.44%, but IBB delivered stronger 1-year returns despite higher volatility.
iShares Biotechnology ETF (IBB) News
Latest headlines that mention IBB, newest first · each headline opens the original publisher
- Last price
- $211.55
- Day change
- +0.50%
- Next earnings
- —
IBB headlines
latest coverageNot much coverage yet. IBB has appeared in only a few headlines lately; new stories show up here as publishers cover it.
Also mentioned with IBB
30d
Headlines that tag both tickers
IBB news alerts
Get an alert by email or push when a new headline mentions IBB.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.